Literature DB >> 19228652

Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis.

Andrea H L Low1, Sindhu R Johnson, Peter Lee.   

Abstract

OBJECTIVE: To investigate ethnic influence on disease manifestations and autoantibody profile in patients of Chinese descent with systemic sclerosis (SSc).
METHODS: In a retrospective study of a multiethnic SSc cohort followed over a 17-year period, disease manifestations and autoantibody profile of patients of European and Chinese descent were compared.
RESULTS: There were 300 patients of European descent and 36 of Chinese descent, with similar proportions of women (81% and 72%, respectively) and patients with diffuse SSc (50% and 56%). Patients of Chinese descent [mean age+/-standard deviation (SD) 52+/-16 yrs; p=0.05] were diagnosed at an older age compared to patients of European descent (mean+/-SD 46+/-12 yrs). Patients of Chinese descent compared to those of European descent had less frequent joint (69% vs 86%; p=0.01) and gastrointestinal involvement (78% vs 94%; p=0.004), but increased prevalence of myositis (17% vs 5%; p=0.01). Patients of Chinese descent had less frequent digital ulceration (36% vs 55%; p=0.04), and an absence of renal crisis. The frequency of cardiac and pulmonary involvement was similar in both groups. More patients of Chinese than of European descent were positive for anti-topoisomerase-I (47% vs 27%; p=0.02), anti-Ro (36% vs 10%; p=0.001), and anti-U1RNP (17% vs 5%; p=0.03) antibodies. The observed differences for anti-topoisomerase-I, anti-Ro, and joint and gastrointestinal manifestations persisted in the subgroup analysis of patients matched for sex, disease subtype, and age at diagnosis.
CONCLUSION: Patients of Chinese descent have milder SSc disease with less frequent joint and gastrointestinal manifestations, less severe vasculopathy, but increased prevalence of myositis and certain autoantibodies. Research is needed to identify determinants (genetic, environmental, and cultural factors) of the relationship between ethnicity and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228652     DOI: 10.3899/jrheum.080915

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Validation of potential classification criteria for systemic sclerosis.

Authors:  Sindhu R Johnson; Jaap Fransen; Dinesh Khanna; Murray Baron; Frank van den Hoogen; Thomas A Medsger; Christine A Peschken; Patricia E Carreira; Gabriela Riemekasten; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

2.  Clinical and serological features of systemic sclerosis in a Chinese cohort.

Authors:  Jiucun Wang; Shervin Assassi; Gang Guo; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Yongqiang Zhao; Haiyan Chu; Jie Liu; Yanyun Ma; Sarah J Kim; Li Jin; Maureen D Mayes; Hejian Zou; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

Review 3.  Systemic sclerosis in Asians: Are there racial differences?

Authors:  Sue-Ann Ng; Andrea Hsiu Ling Low
Journal:  J Scleroderma Relat Disord       Date:  2022-02-03

4.  Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.

Authors:  Meihua Qiu; Xueyuan Nian; Lingling Pang; Pengfei Yu; Shenchun Zou
Journal:  Int J Rheum Dis       Date:  2021-08-21       Impact factor: 2.558

Review 5.  Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?

Authors:  Nedim Durmus; Sung-Hyun Park; Joan Reibman; Gabriele Grunig
Journal:  Curr Opin Rheumatol       Date:  2016-11       Impact factor: 5.006

6.  Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.

Authors:  Andrea H L Low; Sue-Ann Ng; Veronica Berrocal; Benjamin Brennan; Grace Chan; Swee-Cheng Ng; Dinesh Khanna
Journal:  Int J Rheum Dis       Date:  2019-03-06       Impact factor: 2.454

7.  Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.

Authors:  Zhaohua Li; Dan Xu; Xintong Jiang; Ting Li; Yin Su; Rong Mu
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

8.  Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.

Authors:  Shasha Hu; Yong Hou; Qian Wang; Mengtao Li; Dong Xu; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2018-10-22       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.